Abstract
Objective
Animal models have shown a quantal slowing of respiratory pattern when exposed to opioid agonist, in a pattern similar to that observed in central sleep apnea. We postulated that opioid-induced hypoventilation is more likely to be associated with sleep apnea rather than hypoventilation alone. Since we did not have a direct measure of hypoventilation we used hypoxemia as an indirect measure reasoning that significant hypoventilation would not occur in the absence of hypoxemia.
Methods
We conducted a retrospective analysis of 98 consecutive patients on chronic opioid medications who were referred for overnight polysomnography. All patients on chronic opioids seen in the chronic pain clinic were referred for a sleep study regardless of whether they had sleep symptoms or not. Sleep-related hypoxemia was defined as arterial oxyhemoglobin saturation of less than 90% for more than 5 min with a nadir of ≤85%, or greater than 30% of total sleep time at an oxyhemoglobin saturation of less than 90%.
Results
Of the 98 patients, 36% (95% CI 26–46%) had obstructive sleep apnea, 24%, (95% CI 16–33%) had central sleep apnea, 21% (95% CI 14–31%) had combined obstructive and central sleep apnea, in 4% (95% CI 0–10%) sleep apnea was classified as indeterminate, and 15% (95% CI 9–24%) had no sleep apnea. Opioids were potentially responsible for hypoxemia during wakefulness in 10% of patients (95% CI 5–18%) and for hypoxemia during sleep not clearly associated with apneas/hypopneas in 8% of patients (95% CI 4–15%). Two patients (2%, 95% CI 0–7%) had sleep-related hypoxemia in the absence of sleep apnea or hypoxemia during wakefulness.
Conclusions
Patients on chronic opiate therapy for chronic pain have an extremely high prevalence of sleep apnea and nocturnal hypoxemia. Hypoxemia can occur during quiet wakefulness in patients on chronic opioid medications with and without sleep apnea. In patients on chronic opioid therapy, isolated nocturnal hypoxemia without coexisting sleep apnea or daytime hypoxemia is very uncommon.
Similar content being viewed by others
References
American Academy of Sleep Medicine (2005) International classification of sleep disorders, 2nd ed. Diagnostic and coding manual. American Academy of Sleep Medicine, Westchester
Webster L, Choi Y, Desai H et al (2007) Sleep-disordered breathing and chronic opioid therapy. Pain Med doi:10.1111/j.1526-4637.2007.00343.x
Wang D, Teichtahl H, Drummer O et al (2005) Central sleep apnea in stable methadone maintenance treatment patients. Chest 128(3):1348–1356
Bailey PL, Lu JK, Pace NL et al (2000) Effects of intrathecal morphine on the ventilatory response to hypoxia. N Engl J Med 343(17):1228–1234 doi:10.1056/NEJM200010263431705
Teichtahl H, Wang D, Cunnington D et al (2005) Ventilatory responses to hypoxia and hypercapnia in stable methadone maintenance treatment patients. Chest 128(3):1339–1347 doi:10.1378/chest.128.3.1339
Romberg R, Olofsen E, Sarton E et al (2003) Pharmacodynamic effect of morphine-6-glucuronide versus morphine on hypoxic and hypercapnic breathing in healthy volunteers. Anesthesiology 99(4):788–798
Jaffe JH, Martin WR (1990) Opioid agonists and antagonists. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) Goodman and Gilman’s the pharmacological basis of therapeutics, 8th ed. Pergamon, New York, pp 485–521
Shook JE, Watkins WD, Camporisi EM (1990) Differential roles of opioid receptors in respiration, respiratory disease and opiate-induced respiratory depression. Am Rev Respir Dis 33:1–16
Yeadon M, Kitchen I (1989) Opioids and respiration. Prog Neurobiol 33:1–16 doi:10.1016/0301-0082(89)90033-6
Hurl’e MA, Medavilla A, Florez J (1985) Differential respiratory patterns induced by opioids applied to the ventral medullary and dorsal pontine surfaces of cats. Neuropharmacology 24:597–606 doi:10.1016/0028-3908(85)90100-5
Gray PA, Rekling JC, Bocchiaro CM, Feldman JL (1999) Modulation of respiratory frequency by peptidergic input to rhythmogenic neurons in the preBotzinger complex. Science 286:1566–1568 doi:10.1126/science.286.5444.1566
Johnson SM, Smith JC, Feldman JL (1999) Modulation of Gi/o protein-mediated mechanisms. J Appl Physiol 80:120–2133
Morin-Surun MP, Boudinot E, Gacel G, Champagnat J, Roquet BP, Denavit-Saubie M (1984) Pharmacological identification of µ and δ opiate receptors on bulbar respiratory neurons. Eur J Pharmacol 98:235–240 doi:10.1016/0014-2999(84)90594-6
Murakoshi T, Suzue T, Tamai SA (1985) Pharmacological study on respiratory rhythm in the isolated brainstem–spinal cord preparation of the newborn rat. Br J Pharmacol 86:95–104
Lalley PM (2003) Opioid receptor agonist effects on medullary respiratory neurons in the cat: evidence for involvement in certain types of ventilatory disturbances. Am J Physiol Regul Integr Comp Physiol 285:R1287–R1304
Feldman JL, Connelly CA, Ellenberger HH et al (1990) The cardiorespiratory system within the brainstem. Eur J Neurosci 3(suppl.):171
Smith JC, Ellenberger HH, Ballanyi K et al (1991) PreBotzinger complex: a brainstem region that may generate respiratory rhythm in mammals. Science 254:726–729 doi:10.1126/science.1683005
Mellen NM, Janczewski WA, Bocchiaro C et al (2003) Opioid-induced quantal slowing reveals dual networks for respiratory rhythm generation. Neuron 37:821–826 doi:10.1016/S0896-6273(03)00092-8
Smith JC, Morrison DE, Ellenberger HH et al (1989) Brainstem projection to the major respiratory neuron populations in the medulla of the cat. J Comp Neurol 281:69–96 doi:10.1002/cne.902810107
Feldman JL, Del Negro CA (2006) Looking for inspiration: new perspectives on respiratory rhythm. Nat Rev Neurosci 7(3):232–242 doi:10.1038/nrn1871
The Atlas Task force (1992) EEG arousals: scoring rules and examples. A preliminary report from the Sleep Disorders Task Force of the American Sleep Disorders Association. Sleep 15:173–184
US Department of Justice, Drug Enforcement Administration (2005) Automation of reports and consolidated order system (ARCOS) 2—report 7. Available at http://www.deadiversion.usdoj.gov/arcos/retail_drug_summary
Gutstein H, Akil H (2005) Opioid analgesics. In: Hardman JG, Limbird LE, Gilman AG (eds) Goodman and Gilman’s the pharmacological basis of therapeutics, 11th ed. McGraw-Hill, New York
Zech DF, Grond S, Lynch J et al (1995) Validation of World Health Organization guidelines for cancer relief: a 10 year prospective study. Pain 63(1):65–76 doi:10.1016/0304-3959(95)00017-M
Farney RJ, Walker JM, Cloward TV et al (2003) Sleep-disordered breathing associated with long-term opioid therapy. Chest 123(2):632–639
Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165:1217–1239 doi:10.1164/rccm.2109080
Bixler EO, Vgontzas AN, Te Have T et al (1998) Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 157:144–148
Janczewski WA, Onimaru H, Homma I et al (2002) Opioid-resistant respiratory pathway from the preinspiratory neurones to abdominal muscles: in vivo and in vitro study in the newborn rat. J Physiol 545:1017–1026 doi:10.1113/jphysiol.2002.023408
McKay LC, Janczewski WA, Feldman JL (2005) Sleep-disordered breathing after targeted ablation of preBotzinger complex neurons. Nat Neurosci 8:1142–1144 doi:10.1038/nn1517
Unintentional and undetermined poisoning deaths—11 states, 1990–2001. MMWR Morb Mortal Wkly Rep. Centers Dis Contr Prev 53(11):233–228 CDC.
Webster LR (2005) Methadone-related deaths. J Opioid Manage 1(4):211–217
Methadone-Associated Mortality Report of a National Assessment (2004) May 8–9, 2003. CSAT Publication No. 28–03. Rockville, MD: Centers of Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, http://www.dpt.samhsa.gov/medications/methreports.htm
Dolly FR, Block AJ (1982) Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. Am J Med 173:239–243 doi:10.1016/0002-9343(82)90185-1
Acknowledgment
Funding: None.
Work was performed at: Western New York Veteran Affairs Healthcare System, Buffalo, New York; MedOne Medical Sleep Clinic, Sandy, UT; and Lifetree Clinical Research and Pain Clinic, Salt Lake City, UT.
Mohammed Mogri M.D., has no financial or personal conflict of interest in presenting this manuscript.
Himanshu Desai M.D., has no financial or personal conflict of interest in presenting this manuscript.
Lynn Webster M.D., has no financial or personal conflict of interest in presenting this manuscript
Brydon J. B. Grant, M.D., has no financial or personal conflict of interest in presenting this manuscript
M. Jeffrey Mador, M.D., has no financial or personal conflict of interest in presenting this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mogri, M., Desai, H., Webster, L. et al. Hypoxemia in patients on chronic opiate therapy with and without sleep apnea. Sleep Breath 13, 49–57 (2009). https://doi.org/10.1007/s11325-008-0208-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-008-0208-4